Univariate analysis demonstrated that Clinical stage (P = 0.000), LN metastasis (P =0.006), Her2 expression levels (P = 0.001), and Mortalin expression status (P = 0.001) were significantly associated with DFS and OS in patients with breast cancer (Table 3). Here, HSPA9 is linked to breast carcinoma.